Injured tissues

Injured tissues represent biological regions that have sustained damage due to physical trauma, infection, ischemia, or chemical insult, leading to a disruption of cellular homeostasis and structural integrity. Rather than being a single molecular target, injured tissues comprise a complex pathological microenvironment characterized by the release of damage-associated molecular patterns (DAMPs), activation of the inflammatory cascade, and recruitment of immune cells (StatPearls, 'Physiology, Wound Healing', 2023). This environment often exhibits distinct biochemical signatures, such as hypoxia, acidosis, and elevated protease activity, which are frequently exploited in pharmacology for localized drug delivery and regenerative medicine (Nature Reviews Materials, 'Targeted drug delivery to sites of inflammation', 2017). Therapeutic intervention at the site of injured tissues typically involves targeting specific molecular drivers within the tissue, such as cytokines (e.g., TNF-alpha), growth factors (e.g., VEGF), or extracellular matrix components (e.g., collagen exposed during injury). While the term is commonly used in clinical and bioengineering contexts to describe the focus of treatment, it is too broad to be classified as a specific protein or receptor target in drug discovery. Effective management of injured tissues requires a multi-stage approach addressing hemostasis, inflammation, proliferation, and remodeling to restore function and prevent chronic pathological states like fibrosis (Journal of Clinical Investigation, 'Mechanisms of tissue repair: from wound healing to fibrosis', 2012).

Other names

Damaged tissueWounded tissueSite of injuryLesion

Not applicable as a single molecular target; however, therapies targeting injured tissues typically modulate inflammation, promote angiogenesis, or provide scaffold support for regeneration.